Efficacy and safety of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16‐week, randomized, double‐blind, placebo‐controlled phase III trial

The aim of the present study was to assess the efficacy and safety of teneligliptin in combination with metformin in Korean patients with type 2 diabetes mellitus who were inadequately controlled with metformin monotherapy. Patients [glycated haemoglobin (HbA1c) 7.0–10.0%, on stable metformin ≥1000 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, M. K., Rhee, E.‐J., Han, K. A., Woo, A. C., Lee, M.‐K., Ku, B. J., Chung, C. H., Kim, K.‐A., Lee, H. W., Park, I. B., Park, J. Y., Chul Jang, H. C., Park, K. S., Jang, W. I., Cha, B. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680285/
https://www.ncbi.nlm.nih.gov/pubmed/25475929
http://dx.doi.org/10.1111/dom.12424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680285/
https://www.ncbi.nlm.nih.gov/pubmed/25475929
http://dx.doi.org/10.1111/dom.12424

Ejemplares similares